{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:48:16Z","timestamp":1792784896313,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["PRT-K 18-071"],"award-info":[{"award-number":["PRT-K 18-071"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["PLBIO2021-097-PL"],"award-info":[{"award-number":["PLBIO2021-097-PL"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"name":"la Ligue contre le Cancer, the \u201cFondation ARC\u201d, Association Laurette Fugain","id":[{"id":"https:\/\/ror.org\/00x20kz95","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77027-9","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T11:55:23Z","timestamp":1789818923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-thymocyte globulin triggers TNF-dependent cell death in T-cell acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"17","author":[{"given":"Marie Emilie","family":"Dourthe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1520-4633","authenticated-orcid":false,"given":"Mehdi","family":"Latiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Lenglin\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Charbonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaimae","family":"Saji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Hur\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Gillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Doss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8888-2292","authenticated-orcid":false,"given":"Aurore","family":"Touzart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucien","family":"Courtois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1015-9448","authenticated-orcid":false,"given":"Agata","family":"Cieslak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0448-8811","authenticated-orcid":false,"given":"Mathieu","family":"Simonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Ifrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Dombret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2091-7927","authenticated-orcid":false,"given":"Nicolas","family":"Boissel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Baruchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Ghysdael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0520-0493","authenticated-orcid":false,"given":"Elizabeth","family":"Macintyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rousselot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1003-2626","authenticated-orcid":false,"given":"Christine","family":"Tran Quang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume P.","family":"Andrieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6255-5314","authenticated-orcid":false,"given":"Vahid","family":"Asnafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"key":"77027_CR1","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1182\/blood-2002-08-2438","volume":"101","author":"V Asnafi","year":"2003","unstructured":"Asnafi, V. et al. Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. Blood 101, 2693\u20132703 (2003).","journal-title":"Blood"},{"key":"77027_CR2","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1182\/blood-2003-11-3944","volume":"104","author":"V Asnafi","year":"2004","unstructured":"Asnafi, V. et al. Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy. Blood 104, 4173\u20134180 (2004).","journal-title":"Blood"},{"key":"77027_CR3","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1172\/JCI61269","volume":"122","author":"P Van Vlierberghe","year":"2012","unstructured":"Van Vlierberghe, P. & Ferrando, A. The molecular basis of T cell acute lymphoblastic leukemia. J. Clin. Invest. 122, 3398\u20133406 (2012).","journal-title":"J. Clin. Invest."},{"key":"77027_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","volume":"1","author":"AA Ferrando","year":"2002","unstructured":"Ferrando, A. A. et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1, 75\u201387 (2002).","journal-title":"Cancer Cell"},{"key":"77027_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.111","volume":"6","author":"A Desjonqu\u00e8res","year":"2016","unstructured":"Desjonqu\u00e8res, A. et al. Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL study. Blood Cancer J 6, e504 (2016).","journal-title":"Blood Cancer J"},{"key":"77027_CR6","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","volume":"33","author":"C-H Pui","year":"2015","unstructured":"Pui, C.-H. et al. Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 33, 2938\u20132948 (2015).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"77027_CR7","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.3109\/10428194.2014.894191","volume":"55","author":"J Hocking","year":"2014","unstructured":"Hocking, J. et al. Excellent outcomes for adolescents and adults with acute lymphoblastic leukemia and lymphoma without allogeneic stem cell transplant: the FRALLE-93 pediatric protocol. Leuk. Lymphoma 55, 2801\u20132807 (2014).","journal-title":"Leuk. Lymphoma"},{"key":"77027_CR8","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1200\/JCO.2008.18.6916","volume":"27","author":"F Huguet","year":"2009","unstructured":"Huguet, F. et al. Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome\u2013Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study. J. Clin. Oncol. 27, 911\u2013918 (2009).","journal-title":"J. Clin. Oncol."},{"key":"77027_CR9","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1038\/s41375-018-0065-5","volume":"32","author":"ML Cooper","year":"2018","unstructured":"Cooper, M. L. et al. An \u2018off-the-shelf\u2019 fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies. Leukemia 32, 1970\u20131983 (2018).","journal-title":"Leukemia"},{"key":"77027_CR10","doi-asserted-by":"publisher","unstructured":"Teachey, D. T. & Hunger, S. P. Anti-CD7 CAR T cells for T-ALL: impressive early-stage efficacy. Nat. Rev. Clin. Oncol. https:\/\/doi.org\/10.1038\/s41571-021-00556-3 (2021).","DOI":"10.1038\/s41571-021-00556-3"},{"key":"77027_CR11","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1158\/2159-8290.CD-15-0675","volume":"6","author":"A Trinquand","year":"2016","unstructured":"Trinquand, A. et al. Triggering the TCR Developmental Checkpoint Activates a Therapeutically Targetable Tumor Suppressive Pathway in T-cell Leukemia. Cancer Discov 6, 972\u2013985 (2016).","journal-title":"Cancer Discov"},{"key":"77027_CR12","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1182\/blood.2019003801","volume":"136","author":"C Tran Quang","year":"2020","unstructured":"Tran Quang, C. et al. Preclinical efficacy of humanized, non-Fc\u03b3R-binding anti-CD3 antibodies in T-cell acute lymphoblastic leukemia. Blood 136, 1298\u20131302 (2020).","journal-title":"Blood"},{"key":"77027_CR13","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/sj.leu.2404683","volume":"21","author":"M Mohty","year":"2007","unstructured":"Mohty, M. Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 21, 1387\u20131394 (2007).","journal-title":"Leukemia"},{"key":"77027_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0092-8674(03)00521-X","volume":"114","author":"O Micheau","year":"2003","unstructured":"Micheau, O. & Tschopp, J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181\u2013190 (2003).","journal-title":"Cell"},{"key":"77027_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ceb.2009.12.003","volume":"22","author":"DE Christofferson","year":"2010","unstructured":"Christofferson, D. E. & Yuan, J. Necroptosis as an alternative form of programmed cell death. Curr. Opin. Cell Biol. 22, 263\u2013268 (2010).","journal-title":"Curr. Opin. Cell Biol."},{"key":"77027_CR16","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot, D., Latz, E. & Franklin, B. S. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell. Mol. Immunol. 18, 1106\u20131121 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"77027_CR17","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.cell.2007.10.030","volume":"131","author":"E Varfolomeev","year":"2007","unstructured":"Varfolomeev, E. et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 131, 669\u2013681 (2007).","journal-title":"Cell"},{"key":"77027_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/bjh.15829","volume":"185","author":"P Boddu","year":"2019","unstructured":"Boddu, P., Carter, B. Z., Verstovsek, S. & Pemmaraju, N. SMAC mimetics as potential cancer therapeutics in myeloid malignancies. Br. J. Haematol. 185, 219\u2013231 (2019).","journal-title":"Br. J. Haematol."},{"key":"77027_CR19","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1182\/blood-2011-12-274019","volume":"120","author":"P Scheinberg","year":"2012","unstructured":"Scheinberg, P. & Young, N. S. How I treat acquired aplastic anemia. Blood 120, 1185\u20131196 (2012).","journal-title":"Blood"},{"key":"77027_CR20","doi-asserted-by":"publisher","first-page":"805189","DOI":"10.3389\/fped.2021.805189","volume":"9","author":"SJ Keogh","year":"2021","unstructured":"Keogh, S. J., Dalle, J.-H., Admiraal, R. & Pulsipher, M. A. Serotherapy as Graft-Versus-Host Disease Prophylaxis in Haematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukaemia. Front. Pediatr. 9, 805189 (2021).","journal-title":"Front. Pediatr."},{"key":"77027_CR21","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"77027_CR22","doi-asserted-by":"publisher","unstructured":"Numan, Y. et al. First report of clinical response to Venetoclax in Early T-cell Precursor Acute Lymphoblastic Leukemia. JCO Precis. Oncol. 2, https:\/\/doi.org\/10.1200\/PO.18.00127 (2018).","DOI":"10.1200\/PO.18.00127"},{"key":"77027_CR23","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1158\/2159-8290.CD-20-1465","volume":"11","author":"VA Pullarkat","year":"2021","unstructured":"Pullarkat, V. A. et al. Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. Cancer Discov 11, 1440\u20131453 (2021).","journal-title":"Cancer Discov"},{"key":"77027_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.clml.2019.09.608","volume":"20","author":"G Richard-Carpentier","year":"2020","unstructured":"Richard-Carpentier, G. et al. Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia. Clin. Lymphoma Myeloma Leuk. 20, 212\u2013218 (2020).","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"77027_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1152\/physrev.00045.2017","volume":"99","author":"C Dostert","year":"2019","unstructured":"Dostert, C., Grusdat, M., Letellier, E. & Brenner, D. The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond. Physiol. Rev. 99, 115\u2013160 (2019).","journal-title":"Physiol. Rev."},{"key":"77027_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.immuni.2012.01.012","volume":"36","author":"JE Vince","year":"2012","unstructured":"Vince, J. E. et al. Inhibitor of Apoptosis Proteins Limit RIP3 Kinase-Dependent Interleukin-1 Activation. Immunity 36, 215\u2013227 (2012).","journal-title":"Immunity"},{"key":"77027_CR27","doi-asserted-by":"publisher","first-page":"339ra69","DOI":"10.1126\/scitranslmed.aad3099","volume":"8","author":"G Brumatti","year":"2016","unstructured":"Brumatti, G. et al. The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia. Sci. Transl. Med. 8, 339ra69\u2013339ra69 (2016).","journal-title":"Sci. Transl. Med."},{"key":"77027_CR28","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/pbc.23167","volume":"58","author":"PJ Houghton","year":"2012","unstructured":"Houghton, P. J. et al. Initial testing (stage 1) of LCL161, a SMAC mimetic, by the Pediatric Preclinical Testing Program. Pediatr. Blood Cancer 58, 636\u2013639 (2012).","journal-title":"Pediatr. Blood Cancer"},{"key":"77027_CR29","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1021\/jm500176w","volume":"57","author":"SM Condon","year":"2014","unstructured":"Condon, S. M. et al. Birinapant, a smac-mimetic with improved tolerability for the treatment of solid tumors and hematological malignancies. J. Med. Chem. 57, 3666\u20133677 (2014).","journal-title":"J. Med. Chem."},{"key":"77027_CR30","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1158\/0008-5472.CAN-16-0523","volume":"76","author":"J Richmond","year":"2016","unstructured":"Richmond, J. et al. Acute Sensitivity of Ph-like Acute Lymphoblastic Leukemia to the SMAC-Mimetic Birinapant. Cancer Res. 76, 4579\u20134591 (2016).","journal-title":"Cancer Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77027-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77027-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77027-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:02:30Z","timestamp":1792580550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77027-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77027"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77027-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"assertion":[{"value":"18 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10983"}}